Karpas Strategies’s CME Group CME Stock Holding History

Karpas Strategies’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$983K	Hold	5,000	–	–	0.31%	63
2024 Q1	$1.08M	Hold	5,000	–	–	0.33%	60
2023 Q4	$1.05M	Hold	5,000	–	–	0.35%	59
2023 Q3	$1M	Hold	5,000	–	–	0.37%	58
2023 Q2	$926K	Hold	5,000	–	–	0.31%	63
2023 Q1	$958K	Hold	5,000	–	–	0.34%	59
2022 Q4	$841K	Hold	5,000	–	–	0.3%	66
2022 Q3	$886K	Hold	5,000	–	–	0.34%	56
2022 Q2	$1.02M	Hold	5,000	–	–	0.36%	55
2022 Q1	$1.19M	Hold	5,000	–	–	0.37%	56
2021 Q4	$1.14M	Hold	5,000	–	–	0.37%	58
2021 Q3	$1.1M	Hold	5,000	–	–	0.36%	57
2021 Q2	$1.06M	Hold	5,000	–	–	0.38%	57
2021 Q1	$1.02M	Hold	5,000	–	–	0.39%	57
2020 Q4	$910K	Hold	5,000	–	–	0.36%	60
2020 Q3	$837K	Hold	5,000	–	–	0.39%	53
2020 Q2	$813K	Hold	5,000	–	–	0.39%	53
2020 Q1	$865K	Hold	5,000	–	–	0.47%	48
2019 Q4	$1M	Hold	5,000	–	–	0.38%	53
2019 Q3	$1.06M	Hold	5,000	–	–	0.43%	47
2019 Q2	$971K	Hold	5,000	–	–	0.4%	49
2019 Q1	$823K	Hold	5,000	–	–	0.35%	57
2018 Q4	$941K	Hold	5,000	–	–	0.44%	50
2018 Q3	$851K	Hold	5,000	–	–	0.35%	57
2018 Q2	$820K	Hold	5,000	–	–	0.36%	56
2018 Q1	$809K	Hold	5,000	–	–	0.35%	58
2017 Q4	$730K	Hold	5,000	–	–	0.31%	63
2017 Q3	$678K	Hold	5,000	–	–	0.3%	64
2017 Q2	$626K	Hold	5,000	–	–	0.28%	68
2017 Q1	$594K	Hold	5,000	–	–	0.27%	69
2016 Q4	$577K	Hold	5,000	–	–	0.27%	65
2016 Q3	$523K	Hold	5,000	–	–	0.26%	72
2016 Q2	$487K	Hold	5,000	–	–	0.24%	75
2016 Q1	$480K	Hold	5,000	–	–	0.25%	74
2015 Q4	$453K	Hold	5,000	–	–	0.24%	72
2015 Q3	$464K	Hold	5,000	–	–	0.26%	74
2015 Q2	$465K	Hold	5,000	–	–	0.23%	75
2015 Q1	$474K	Hold	5,000	–	–	0.23%	77
2014 Q4	$443K	Hold	5,000	–	–	0.21%	80
2014 Q3	$400K	Hold	5,000	–	–	0.2%	85
2014 Q2	$355K	Hold	5,000	–	–	0.18%	88
2014 Q1	$370K	Hold	5,000	–	–	0.2%	87
2013 Q4	$392K	Hold	5,000	–	–	0.22%	77
2013 Q3	$369K	Hold	5,000	–	–	0.22%	77
2013 Q2	$380K	Buy	+5,000	New	+$328K	0.23%	74

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Karpas Strategies's CME Position: Q2 2024 in Review

Karpas Strategies held its CME Group (CME) position steady in Q2 2024 at 5,000 shares worth $983K. The position accounts for 0.31% of the portfolio, ranked #63.

Karpas Strategies first reported a position in CME in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.19M in Q1 2022. 1,378 funds tracked by Wall St. Rank hold CME as of Q2 2024.

Karpas Strategies held 5,000 shares of CME Group worth $983K as of Q2 2024.
Karpas Strategies left its CME Group share count unchanged in Q2 2024.
CME Group made up 0.31% of Karpas Strategies's portfolio in Q2 2024, its #63 holding.
Karpas Strategies first reported a position in CME Group in Q2 2013 and has held it in 45 quarters since.
Karpas Strategies's CME Group position peaked at $1.19M in Q1 2022.
1,378 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.